A multicenter, observational, and prospective study to investigate frailty status in adult patients eligible for commercial CAR T-cell therapies and evaluate its impact on therapy outcomes
Latest Information Update: 10 Feb 2025
At a glance
- Drugs Axicabtagene ciloleucel (Primary)
- Indications B-cell lymphoma; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
Most Recent Events
- 10 Feb 2025 New trial record